Comparative Evaluation of the Efficacy of Varun Twak Lepaguti versus Krushnatiladi Lepaguti in Vyanga (Melasma): A Double-Blind Randomised Controlled Trial
DOI:
https://doi.org/10.47552/ijam.v17i3.6861Keywords:
Vyanga, Melasma, Krushnatiladi Lepaguti, Varun Twak Lepaguti, HyperpigmentationAbstract
Introduction: In the present era, beauty and skin health significantly influence self-confidence and quality of life. Melasma, a common hyperpigmentary disorder correlated with Vyanga in Ayurveda, affects mainly females and causes facial discoloration. Conventional treatments often produce side effects, prompting interest in safe Ayurvedic alternatives. Aim and Objectives: To evaluate and compare the efficacy of Varun Twak Lepaguti and Krushnatiladi Lepaguti in the management of Vyanga (melasma). Material and Method: A randomized double-blind clinical trial was conducted on 62 patients with Vyanga, divided equally into two groups. Group A received Varun Twak Lepaguti and Group B received Krushnatiladi Lepaguti, both applied locally with Godugdha once daily for 30 days. Assessments were made using subjective (discoloration, roughness, burning, itching, oiliness) and objective parameters (patch size, Von Luschan’s scale, Melasma Severity Index). Observation and Results: Both groups showed statistically significant improvement in all parameters (p<0.0001). However, Group B demonstrated greater improvement in discoloration, roughness, burning sensation, patch size, and MSI score, with highly significant intergroup differences (p<0.05). Conclusion: Krushnatiladi Lepaguti proved more effective than Varun Twak Lepaguti in treating Vyanga, offering a safe, economical, and holistic Ayurvedic alternative for melasma management.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 International Journal of Ayurvedic Medicine

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.

